PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28500234-6	2017	Niclosamide, a potent inhibitor of AR variants, significantly enhanced bicalutamide treatment.	Niclosamide	0-11	androgen receptor	Homo sapiens	35-37	
28500234-7	2017	Niclosamide and bicalutamide combination treatment not only suppressed AR and AR variants expression and inhibited their recruitment to the PSA promoter, but also significantly induced apoptosis in bicalutamide- and enzalutamide-resistant CWR22Rv1 and C4-2B MDVR cells.	Niclosamide	0-11	androgen receptor	Homo sapiens	71-73	
28500234-7	2017	Niclosamide and bicalutamide combination treatment not only suppressed AR and AR variants expression and inhibited their recruitment to the PSA promoter, but also significantly induced apoptosis in bicalutamide- and enzalutamide-resistant CWR22Rv1 and C4-2B MDVR cells.	Niclosamide	0-11	androgen receptor	Homo sapiens	78-80